Literature DB >> 9373238

Localization of Kaposi's sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma.

J W Said1, M R Rettig, K Heppner, R A Vescio, G Schiller, H J Ma, D Belson, A Savage, I P Shintaku, H P Koeffler, H Asou, G Pinkus, J Pinkus, M Schrage, E Green, J R Berenson.   

Abstract

We have recently demonstrated the presence of Kaposi's sarcoma-associated herpesvirus (KSHV) in cultured bone marrow (BM) stromal dendritic cells from all patients with myeloma studied. To show that these findings were not an artifact of tissue culture, we performed in situ hybridization (ISH) and polymerase chain reaction (PCR) to detect KSHV in BM core biopsies. Using ISH to open reading frame-72 (ORF 72), we localized KSHV to BM dendritic cells in 17 of 20 patients with myeloma, 2 patients with plasmacytosis associated with the acquired immunodeficiency syndrome, and 1 case of aplastic anemia. In contrast, BM from normal subjects (n = 4) and patients with lymphoma and leukemia (n = 21) did not contain KSHV. PCR amplification with KSHV primers demonstrated product in fresh BM biopsy samples from 6 of 7 myeloma patients, whereas three normal marrows contained no amplified product. These findings suggest that KSHV, possibly through alterations in the BM microenvironment and production of viral interleukin-6 (vIL-6), may stimulate and maintain abnormal plasma cell proliferation in myeloma and related disorders.

Entities:  

Mesh:

Year:  1997        PMID: 9373238

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues.

Authors:  M Teitell; M A Damore; G G Sulur; D E Turner; M H Stern; J W Said; C T Denny; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions.

Authors:  G Gaidano; E Castaños-Velez; P Biberfeld
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

Review 3.  Molecular diagnostic approach to non-Hodgkin's lymphoma.

Authors:  D A Arber
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

4.  Polymerase chain reaction detection of Kaposi's sarcoma-associated herpesvirus-optimized protocols and their application to myeloma.

Authors:  L Pan; L Milligan; J Michaeli; E Cesarman; D M Knowles
Journal:  J Mol Diagn       Date:  2001-02       Impact factor: 5.568

5.  Myeloid neighborhood in myeloma: cancer's underbelly?

Authors:  Madhav V Dhodapkar
Journal:  Am J Hematol       Date:  2009-07       Impact factor: 10.047

6.  Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus.

Authors:  Chuang-Jiun Chiou; Lynn J Poole; Peter S Kim; Dolores M Ciufo; Jennifer S Cannon; Colette M ap Rhys; Donald J Alcendor; Jian-Chao Zong; Richard F Ambinder; Gary S Hayward
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells.

Authors:  R Renne; D Blackbourn; D Whitby; J Levy; D Ganem
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

8.  Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma.

Authors:  Kavita M Dhodapkar; Scott Barbuto; Phillip Matthews; Anjli Kukreja; Amitabha Mazumder; David Vesole; Sundar Jagannath; Madhav V Dhodapkar
Journal:  Blood       Date:  2008-07-30       Impact factor: 22.113

9.  Cloning and functional analysis of Kaposi's sarcoma-associated herpesvirus DNA polymerase and its processivity factor.

Authors:  K Lin; C Y Dai; R P Ricciardi
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 10.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.